A, K., B, C., A, d. S., E, M., AH, K., CR, G., . . . H, D. (2023). Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis. International journal of molecular sciences, 24(24), . https://doi.org/10.3390/ijms242417454
Chicago Style (17th ed.) CitationA, Kwakowsky, Chawdhary B, de Souza A, Meyer E, Kaye AH, Green CR, Stylli SS, and Danesh-Meyer H. "Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis." International Journal of Molecular Sciences 24, no. 24 (2023). https://doi.org/10.3390/ijms242417454.
MLA (9th ed.) CitationA, Kwakowsky, et al. "Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis." International Journal of Molecular Sciences, vol. 24, no. 24, 2023, https://doi.org/10.3390/ijms242417454.